We make your science Manufacturable
We bridge the gap between discovery science and GMP manufacturing by designing, engineering, de-risking, and locking your cell therapy process for clean transfer.
The Translational Partner
for Cell Therapy
NueCell Bio is the California-based translational partner for advanced cell therapies. We are a dedicated team bridging discovery and GMP manufacturing, uniquely equipped to accelerate the delivery of life-changing treatments to patients. At the core of our approach is NueStack™, our development framework with modular technology stacks configured to each program’s complexity, providing a robust path from laboratory research to GMP-compliant manufacturing.
De-Risk Biology, enable manufacturing, transfer to GMP
We connect the value chain and meet you where you are.
The dedicated translational layer between discovery and GMP
Built for the Space Between Discovery and GMP
Cell source decisions, cellular engineering, and manipulation that require early decisions that can be scaled from early discovery to commercial manufacturing.
Reprogramming and gene-editing platforms matched to your biology and target product profile, not chosen for convenience, drawing on decades of hands-on toolbox depth across modalities.
Processes and analytics are built with cGMP-ready raw materials, scaled-down models, and qualified assays, so GMP technology transfer is a replication exercise, not a reinvention.
Gap assessments, QbD-driven workflows, and multiple critical-step coverage de-risk the highest-cost decisions before clinical entry.
40+
programs facilitated by NueStacks™
95%
on-time delivery track record
NueStack™
Pre-Built Stacks.
Expertly Assembled.
Proven technology stacks that address a development program’s needs, expertly assembled and tailored by a team with decades of practical experience and knowledge.
OUR EXPERTISE
Wide-Ranging Modality Expertise
Cell Types
- Primary cells (T, NK, Myeloid, etc.)
- Stem & progenitor cells (HSC, PSC, MSC, etc.)
- Specialized cells (differentiated stem cells, primary therapeutic cells)
Product architecture
- Autologous
- Adherent
- Scale-up
- Allogeneic
- Suspension
- Scale-out
Engineering Capabilities
- Gene editing
- Viral delivery
- Non-viral delivery
- Cellular reprogramming
By the Numbers
Experience that Shows
2 days
median response time for new program inquiries; actionable plan, not a sales pitch
26,300 ft2
of purpose-built San Diego facility; operated in compliance with ISO 9001 Quality Management Standard since launch
20+
scientific publications
95%+
right-first-time rate
5
years of successful ISO 9001 certification
40+
projects delivered to date
CONTACT US
Let’s Bridge Your Science to GMP
Tell us about your program. Our team will respond within two business days with an actionable plan and clear next steps — no procurement gauntlet, no boilerplate.